Johnson & Johnson and Crucell N.V. have entered an agreement under which J&J, through an affiliate, would acquire all outstanding equity of Crucell for approximately $2.4 billion in cash. J&J currently owns 17.9% of Crucell’s outstanding shares. Once the offer is finalized J&J expects to maintain Crucell’s existing facilities, to retain its senior management and, generally, to maintain current employment levels. J&J also plans to keep Crucell as the center for ...